Stay updated on Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Sign up to get notified when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.

Latest updates to the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the history and the prior government funding notice was removed.SummaryDifference0.9%

- Check21 days agoChange DetectedA site-wide funding notice was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check28 days agoChange DetectedThe study history page adds a glossary toggle and a new Revision: v3.4.0 label, with additions shown in green and deletions in red to clarify changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedThe study record history now includes a new revision entry v3.3.4 and removes the previous revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history shows a new revision entry v3.3.2 and removal of v3.3.1, which are minor updates to the historical record.SummaryDifference0.1%

Stay in the know with updates to Uproleselan Combo in R/R AML Chinese Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan Combo in R/R AML Chinese Patients Clinical Trial page.